Dr. Michael Joseph Maricic, MD

Dr. Maricic practices at Catalina Pointe Arthritis & Rheumatology Specialists in Tucson, Arizona.

Dr. Maricic's NPI, 1720179971, was assigned on September 27, 2006. Dr. Maricic holds Arizona license AZ13959.

Dr. Maricic's primary practice is Catalina Pointe Arthritis & Rheumatology Specialists, at 7520 N Oracle Rd, Tucson, AZ 85704 in Pima County. The practice phone is (520) 408-1133.

Dr. Maricic's primary practice is Catalina Pointe Arthritis & Rheumatology Specialists in Tucson, Arizona. Dr. Maricic is also affiliated with Tucson Medical Center. The medical group on file is Catalina Pointe Arthritis and Rheumatology Specialists. Dmand AI also links Dr. Maricic to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maricic practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Maricic's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Maricic is licensed in Arizona.

CMS data shows 144,027 Medicare services from Dr. Maricic across 23 procedure codes in 2024, for 1,172 Medicare patients. Medicare paid $2,018,311 for them. Every service was in an office.

CMS counts 1,172 Medicare patients who saw Dr. Maricic in 2024. The largest group is 75 to 84, with 568 patients. 75% of them have arthritis, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maricic's median patient age at 75, with 80% women.

In 2024, Dr. Maricic wrote 4,415 Medicare Part D claims for 688 patients. 89% of them were for generic drugs. CMS names the drug for 4,096 of them, across 55 drugs with 11 or more claims each, at $2,927,298 in total drug cost. In 2023, CMS named 4,306 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Maricic for performance year 2024, reported as part of a group. Dr. Maricic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maricic as offering telehealth.

Dmand AI links 7 papers to Dr. Maricic, published from 2010 to 2018. The most frequent topics are Osteoporosis, Absorptiometry, Photon and Bone Density. Dr. Maricic's most frequent co-authors are Akila Balasubramanian, MD, Robin K. Dore, MD and Sundeep Khosla, MD.

CMS Open Payments shows 550 general payments to Dr. Maricic from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Amgen Inc. paid the most, $151,641.